KCTD8: A Comprehensive Review of Function, Localization, and Signaling Pathways

Introduction and Summary

KCTD8 (Potassium Channel Tetramerization Domain Containing 8) is a 473-amino acid cytoplasmic protein encoded by the KCTD8 gene located on human chromosome 4p13 (UniProt: Q6ZWB6, NCBI Gene ID: 386617). The protein is characterized by an N-terminal BTB/POZ (bric-a-brac, tramtrak, and broad complex/poxvirus zinc finger) domain and a unique C-terminal domain architecture comprising H1 and H2 homology domains. The primary molecular function of KCTD8 is to serve as an auxiliary subunit of GABAB receptors, where it modulates receptor pharmacology and signaling kinetics[schwenk-2010-gabab-kctd-auxiliary-abstract]. As a member of the KCTD family clade F alongside KCTD12 and KCTD16, KCTD8 plays a specialized role in neural signaling by producing non-desensitizing receptor responses and facilitating the axonal trafficking of GABAB receptors to presynaptic terminals[seddik-2012-kctd-desensitization-abstract][ren-2022-kctd8-habenula-abstract].

The discovery of KCTD proteins as auxiliary subunits of GABAB receptors in 2010 resolved a long-standing puzzle in neuroscience: why cloned GABAB1/GABAB2 heteromeric receptors failed to reproduce the functional diversity observed in native receptors. Using functional proteomics, Schwenk and colleagues demonstrated that native GABAB receptors are high-molecular-mass complexes containing not only the principal GABAB1 and GABAB2 subunits but also tetrameric (now understood to be pentameric) assemblies of KCTD8, KCTD12, KCTD12b, or KCTD16[schwenk-2010-gabab-kctd-auxiliary-abstract]. This foundational work established that KCTD proteins determine the pharmacology and kinetics of GABAB receptor responses through their effects on agonist potency, G-protein signaling onset, and receptor desensitization.

Structural Features and Domain Architecture

KCTD8 possesses a modular structural organization that is critical for its function as a GABAB receptor auxiliary subunit. The protein contains three major functional domains: the N-terminal BTB/POZ tetramerization domain (T1), the H1 homology domain, and uniquely among GABAB-associated KCTDs, an additional C-terminal H2 homology domain[seddik-2012-kctd-desensitization-abstract]. This three-domain architecture distinguishes KCTD8 from KCTD12 and KCTD12b, which lack the H2 domain, and has important functional consequences for receptor signaling.

The BTB domain of KCTD8 shares 33-43% sequence homology with the T1 domains of voltage-gated potassium (Kv) channels, from which the KCTD family derives its name[teng-2019-kctd-neurodevelopment-abstract]. However, despite this sequence similarity, KCTD BTB domains form pentameric rather than tetrameric assemblies. Structural studies using electron microscopy and crystallography have confirmed that KCTD8 forms stable pentamers through its BTB domain, and AlphaFold predictions support this oligomeric state as the biologically relevant form[esposito-2022-alphafold-kctd-abstract]. The pentameric BTB assembly creates an asymmetric arrangement that wraps around the C-terminal tail of the GABAB2 receptor subunit, with key phenylalanine residues making extensive contacts critical for binding[zheng-2019-kctd-structural-abstract].

The crystal structure of the human KCTD8 H1 domain has been solved at 2.80 angstrom resolution (PDB: 6G57)[pinkas-2018-kctd8-h1-structure-summary]. The H1 domain adopts a distinctive propeller-like architecture where five subunits assemble to generate a central cavity delimited by terminal beta-strands that constitute the blades of the propeller. Notably, the structure reveals an "sticky" nature of exposed beta-strands that can mediate additional protein-protein interactions. For KCTD8, KCTD12, and KCTD16, the BTB and CTD domains are separated by a large unstructured stretch, and the opening of the pentamer is functionally important as it favors binding to the GABAB2 receptor[esposito-2022-alphafold-kctd-abstract].

A defining structural feature of KCTD8 is its conserved H2 homology domain, which is not sequence-related to the H1 domain. The H2 domain functions as an antagonist of receptor desensitization, counteracting the desensitization-promoting activity of the H1 domain[seddik-2012-kctd-desensitization-abstract]. This molecular mechanism explains why KCTD8-containing GABAB receptors generate largely non-desensitizing responses, in contrast to KCTD12-containing receptors which exhibit pronounced desensitization due to the absence of an inhibitory H2 domain and the presence of a critical T/NFLEQ motif in their H1 domains.

Primary Molecular Function: GABAB Receptor Auxiliary Subunit

The primary molecular function of KCTD8 is to serve as an auxiliary subunit of GABAB receptors, the principal G-protein-coupled receptors for gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain[schwenk-2010-gabab-kctd-auxiliary-abstract]. GABAB receptors regulate synaptic transmission and signal propagation by controlling the activity of voltage-gated calcium channels and G-protein-coupled inwardly rectifying potassium (GIRK/Kir3) channels. The incorporation of KCTD8 into GABAB receptor complexes fundamentally alters the pharmacological and kinetic properties of receptor signaling.

KCTD8 associates with the cytoplasmic C-terminal tail of the GABAB2 subunit as a pentameric assembly. This co-assembly increases agonist potency at GABAB receptors and markedly alters G-protein signaling by accelerating the onset of receptor responses[schwenk-2010-gabab-kctd-auxiliary-abstract]. The mechanism involves the H1 domain of KCTD proteins engaging Gbeta-gamma subunits with high affinity (approximately 185 nM for the related KCTD12), exhibiting remarkable cooperativity where only full 5:5 KCTD-Gbeta-gamma complexes form under substoichiometric conditions[zheng-2019-kctd-structural-abstract].

The critical functional distinction of KCTD8 compared to other GABAB-associated KCTDs lies in its effect on receptor desensitization. KCTD12 and KCTD12b produce strongly desensitizing receptor responses, while KCTD8 and KCTD16 generate largely non-desensitizing responses[seddik-2012-kctd-desensitization-abstract]. This difference arises from the presence of the H2 domain in KCTD8, which antagonizes the desensitization-promoting activity of the H1 domain. The H2 domain of KCTD8 effectively prevents the receptor desensitization that would otherwise be induced by the H1 domain, leading to sustained signaling upon prolonged agonist exposure.

Beyond homo-oligomeric assembly, KCTD proteins can form hetero-oligomers that confer unique kinetic properties to GABAB receptor responses. Fritzius and colleagues demonstrated that approximately two-thirds of KCTD16 proteins in the adult mouse hippocampus associate with KCTD12 to form hetero-oligomers[fritzius-2017-kctd-hetero-oligomers-abstract]. These hetero-oligomeric assemblies directly bind to both the receptor and the associated G-protein, producing moderately desensitizing potassium currents that differ from the strongly desensitizing or slowly deactivating responses produced by individual KCTD proteins. This capacity for hetero-oligomerization substantially increases the molecular and functional repertoire of native GABAB receptors.

Cellular Localization and Tissue Distribution

KCTD8 is a cytoplasmic protein that functions at synaptic membranes through its association with membrane-anchored GABAB receptor complexes. Unlike integral membrane proteins, KCTD8 lacks transmembrane domains and instead localizes to synaptic compartments by binding to the intracellular C-terminal tail of the GABAB2 subunit[schwenk-2010-gabab-kctd-auxiliary-abstract]. Gene Ontology annotations predict that KCTD8 is active at both postsynaptic and presynaptic regions, specifically localizing to the postsynaptic membrane, presynaptic membrane, and presynaptic active zone membrane structures.

The tissue distribution of KCTD8 is notably restricted compared to other GABAB-associated KCTDs. While KCTD12 and KCTD16 exhibit widespread expression throughout the brain, KCTD8 and KCTD12b have more limited expression patterns[metz-2011-kctd-distribution-brain-abstract]. In the adult mouse brain, KCTD8 is strongly expressed in the medial habenula (MHb) and, to a lesser extent, in interpeduncular nucleus (IPN) neurons. Outside these regions, KCTD8 shows only weak expression in the cerebellum and superior colliculus. This restricted expression pattern suggests that KCTD8 serves specialized functions in particular neural circuits rather than broadly modulating GABAB signaling throughout the brain.

Human Protein Atlas data confirm that KCTD8 shows cytoplasmic expression in the brain, with the highest levels in the cerebellum (16.9 nTPM), followed by basal ganglia (9.3 nTPM), spinal cord (7.8 nTPM), and cerebral cortex (7.2 nTPM). The gene is classified as "group enriched" with specificity for brain and retina tissues, achieving a Tau specificity score of 0.83. Outside the nervous system, KCTD8 expression is minimal, with low levels detected in the retina (6.3 nTPM) and thyroid gland (2.8 nTPM), while most other tissues show undetectable or negligible expression.

Within the medial habenula, KCTD8 co-localizes with cholinergic markers and GABAB receptors. Immunohistochemistry studies have demonstrated the distribution of KCTD8 in the MHb of wild-type mice, with immunoreactivities showing co-localization with choline acetyltransferase (ChAT), confirming expression in cholinergic neurons[turecek-2021-kctd8-cav23-abstract]. In ventral MHb terminals projecting to the rostral IPN, KCTD8, KCTD12b, and Cav2.3 calcium channels co-localize at presynaptic active zones, with over 97% of Cav2.3-positive active zones also containing KCTD8 and GABAB1.

Signaling Pathways and Mechanisms

KCTD8 participates in GABAB receptor signaling through the regulation of G-protein-coupled inwardly rectifying potassium (GIRK) channels and voltage-gated calcium channels. The central mechanism involves the sequestration of Gbeta-gamma subunits following GABAB receptor activation, which controls the temporal dynamics of downstream effector activation[zheng-2019-kctd-structural-abstract].

Upon GABAB receptor activation by GABA, the heterotrimeric G-protein (Gi/o) bound to the receptor dissociates into Galpha-GDP and Gbeta-gamma subunits. The released Gbeta-gamma directly activates GIRK channels, producing inhibitory potassium currents that hyperpolarize neurons. KCTD proteins tethered to the receptor's cytoplasmic tail can engage and sequester these Gbeta-gamma subunits through their H1 domains, effectively stripping them from GIRK channels through higher-affinity binding[zheng-2019-kctd-structural-abstract]. This Gbeta-gamma sequestration mechanism enables rapid desensitization of GIRK currents following receptor activation, providing tight temporal control of signaling that is not achievable with the slower beta-arrestin pathway used to desensitize most GPCRs.

However, KCTD8 produces distinct signaling outcomes compared to desensitizing KCTDs like KCTD12. The presence of the H2 domain in KCTD8 antagonizes desensitization, resulting in sustained GIRK channel activation during prolonged agonist exposure[seddik-2012-kctd-desensitization-abstract]. This means that KCTD8-containing GABAB receptors generate non-desensitizing or slowly deactivating potassium currents, maintaining inhibitory signaling over extended periods.

Beyond modulating GIRK channel kinetics, KCTD8 has emerged as a direct regulator of voltage-gated calcium channels at presynaptic terminals. Turecek and colleagues demonstrated that KCTD8 and KCTD12b, but not KCTD12, bind directly to Cav2.3 (R-type) calcium channels at the plasma membrane[turecek-2021-kctd8-cav23-abstract]. Importantly, KCTD8 potentiates Cav2.3-mediated calcium currents, with significant increases in current density observed in cells co-expressing KCTD8 compared to control cells. This potentiation of presynaptic calcium channels by KCTD8 increases neurotransmitter release probability, representing a GABAB receptor-independent function of this auxiliary subunit.

The functional consequences of KCTD8-Cav2.3 interaction are evident in the MHb-IPN pathway. KCTD8 localizes to the peri-synaptic region with lower particle densities inside the active zone proper. In KCTD12b knockout mice, a compensatory mechanism increases KCTD8 density in the active zone approximately twofold, correlating with enhanced release probability[turecek-2021-kctd8-cav23-abstract]. This finding reveals that KCTD8 can modulate synaptic transmission through direct effects on calcium channel function, independent of its role in GABAB receptor desensitization.

KCTD8 also plays a critical role in the axonal trafficking of GABAB receptors to presynaptic terminals. Ren and colleagues demonstrated that KCTD8 and KCTD12 facilitate GABAB receptor expression in axonal terminals of habenula cholinergic neurons[ren-2022-kctd8-habenula-abstract]. Knockout of KCTD8/12/16 substantially reduced GABAB-mediated potentiation of glutamate release, an effect specific to axonal terminals rather than neuronal cell bodies. Overexpression of either KCTD8 or KCTD12 reversed these reductions, confirming the essential role of these auxiliary subunits in presynaptic GABAB receptor function.

Role in Neural Circuits and Behavior

The restricted expression of KCTD8 in the medial habenula and interpeduncular nucleus positions it as a key regulator of the habenulo-interpeduncular pathway, a brain circuit involved in aversion, fear, and reward processing. The medial habenula receives input from limbic forebrain structures and projects via the fasciculus retroflexus to the interpeduncular nucleus, which in turn influences midbrain monoaminergic systems. GABAB receptors in this pathway produce unusual excitatory effects by enhancing glutamate release from MHb terminals, and KCTD8 is essential for this presynaptic excitation[ren-2022-kctd8-habenula-abstract].

Studies in mice have demonstrated that KCTD8/12 auxiliary subunits modulate the expression and function of GABAB receptors in habenula cholinergic neurons, thereby affecting aversion memory processing in adult mice[ren-2022-kctd8-habenula-abstract]. The pathway modulates aversion-related memory processes, and the isoform-specific roles of KCTD proteins in enriching axonal GABAB receptor expression have direct impacts on fear memory formation.

KCTD8 and Brain Development

A genome-wide association study (GWAS) identified KCTD8 as a genetic modifier of brain size in human populations, particularly in the context of adverse intrauterine environments[paus-2012-kctd8-brain-gwas-abstract]. Paus and colleagues found that genetic variation in the KCTD8 locus (rs716890) is significantly associated with brain size in female adolescents (P = 5.40 x 10^-09). Remarkably, the KCTD8 locus showed a strong gene-environment interaction with prenatal exposure to maternal cigarette smoking (PEMCS), explaining up to 21% of variance in cortical area and cortical folding in exposed girls. This association was replicated in an independent cohort using head circumference measurements at age 7 years.

The proposed mechanism for this gene-environment interaction involves KCTD8's potential role in modulating hypoxia-induced loss of intracellular potassium, which could promote apoptosis in the developing brain[paus-2012-kctd8-brain-gwas-abstract]. During the first trimester, such an effect would reduce the number of progenitor cells, with exponential consequences on the final number of neurons and cortical area. During the second and third trimesters, this mechanism could lead to a reduction of postmitotic neurons. Notably, this interaction was observed exclusively in female offspring, suggesting sex-specific effects of KCTD8 on brain development that may be related to differential androgen exposure or other sex-linked factors.

This GWAS finding suggests that KCTD8 may have developmental functions beyond its established role as a GABAB receptor auxiliary subunit, potentially involving regulation of cellular potassium homeostasis or apoptosis during brain development. The sex-specificity and environmental interaction of this association highlight the complex interplay between genetic variation and environmental factors in shaping brain structure.

Cancer Biology: A Non-Canonical Function

Beyond its well-characterized neuronal functions, KCTD8 has recently been identified as a tumor suppressor in hepatocellular carcinoma (HCC), revealing an unexpected role in cancer biology[zhou-2024-kctd8-cancer-abstract]. Zhou and colleagues found that KCTD8 is epigenetically silenced through promoter DNA methylation in 44.83% of HCC cases, and this methylation pattern serves as an independent poor prognostic marker.

The tumor-suppressive function of KCTD8 in HCC operates through inhibition of the PI3K/AKT/mTOR signaling pathway, which is distinct from its neuronal function as a GABAB receptor auxiliary subunit. Reintroduction of KCTD8 into cancer cells suppresses proliferation, migration, and invasion while inducing apoptosis both in vitro and in vivo. The mechanism involves physical interaction between KCTD8 and IMPDH2 (inosine monophosphate dehydrogenase 2), which is involved in PI3K signaling. KCTD8 expression reduces levels of PI3K110beta, phospho-AKT, and phospho-mTOR, indicating inhibition of this oncogenic signaling cascade[zhou-2024-kctd8-cancer-abstract].

This finding expands the functional repertoire of KCTD8 beyond neuroscience and suggests that KCTD proteins may have tissue-specific functions determined by their local interaction partners. The epigenetic silencing of KCTD8 in cancer also highlights potential therapeutic strategies targeting methylation to restore KCTD8 expression in malignancies.

Evolutionary and Family Context

KCTD8 belongs to a family of 25-26 KCTD proteins in humans, which share the defining BTB/POZ domain but exhibit diverse functions across different cellular contexts[teng-2019-kctd-neurodevelopment-abstract]. Within this family, KCTD8, KCTD12, and KCTD16 constitute clade F, which shares the specialized function of associating with GABAB receptors. KCTD12b is found in mice but not humans. The phylogenetic relationship among clade F members is reflected in their shared domain architecture, with KCTD8 and KCTD16 both possessing the H2 domain while KCTD12 and KCTD12b lack this element.

The evolutionary conservation of KCTD8 across mammals suggests important physiological functions. Mouse Kctd8 shows 476 amino acids compared to human KCTD8's 473 amino acids, with highly conserved domain architecture. The restricted expression pattern of KCTD8 in specific brain nuclei is also conserved between species, indicating that specialized roles in habenular circuitry represent an evolutionarily maintained function.

The nomenclature "potassium channel tetramerization domain" reflects the original observation that KCTD BTB domains share sequence homology with T1 domains of Kv channels. However, it is now clear that KCTD proteins do not directly associate with or regulate potassium channels in the manner implied by this name. Instead, the BTB domains mediate pentamerization of KCTD subunits and interaction with partner proteins such as GABAB2 or Cullin3 E3 ubiquitin ligases[esposito-2022-alphafold-kctd-abstract].

Open Questions

Several important questions remain regarding KCTD8 function and regulation:

1. Hetero-oligomerization specificity: While KCTD proteins can form hetero-oligomers, the rules governing which combinations form in vivo and how these are regulated remain unclear. Whether KCTD8 preferentially hetero-oligomerizes with KCTD12 or KCTD16 in the medial habenula, and how this affects signaling, requires further investigation.

2. Developmental regulation: The expression of KCTD8 changes during brain development, but the functional significance of these changes and the transcriptional mechanisms controlling KCTD8 expression are not well understood.

3. GABAB receptor-independent functions: The discovery that KCTD8 directly binds and potentiates Cav2.3 calcium channels raises questions about other potential binding partners and functions that operate independently of GABAB receptors.

4. Cancer biology mechanisms: The tumor-suppressive function of KCTD8 through IMPDH2 interaction and PI3K pathway inhibition requires further mechanistic characterization. Whether this represents a tissue-specific function or a more general property of KCTD8 in non-neuronal cells remains to be determined.

5. Therapeutic potential: Given the role of KCTD proteins in modulating GABAB receptor pharmacology and their association with neuropsychiatric disorders, whether KCTD8-selective modulators could have therapeutic applications warrants exploration.

6. Structural dynamics: How the H2 domain mechanistically antagonizes H1-mediated desensitization at the molecular level remains incompletely understood and would benefit from additional structural studies of full-length KCTD8 in complex with GABAB receptors.

7. Relationship to habenular dysfunction: Given the strong expression of KCTD8 in the medial habenula and the role of this structure in depression, anxiety, and addiction, whether KCTD8 variants or expression changes contribute to these disorders merits investigation.

References

• schwenk-2010-gabab-kctd-auxiliary-abstract: Schwenk J, Metz M, Zolles G, et al. (2010) Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 465(7295):231-235. DOI: 10.1038/nature08964. PMID: 20400944.

• seddik-2012-kctd-desensitization-abstract: Seddik R, Jungblut SP, Silander OK, et al. (2012) Opposite Effects of KCTD Subunit Domains on GABAB Receptor-mediated Desensitization. Journal of Biological Chemistry 287(47):39869-39877. DOI: 10.1074/jbc.M112.412767. PMID: 23035123.

• zheng-2019-kctd-structural-abstract: Zheng S, Abreu N, Levitz J, Kruse AC. (2019) Structural basis for KCTD-mediated rapid desensitization of GABAB signaling. Nature 567(7746):127-131. DOI: 10.1038/s41586-019-0990-0. PMID: 30814734.

• metz-2011-kctd-distribution-brain-abstract: Metz M, Gassmann M, Fakler B, Schaeren-Wiemers N, Bettler B. (2011) Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain. Journal of Comparative Neurology 519(8):1435-1454. DOI: 10.1002/cne.22610. PMID: 21452234.

• teng-2019-kctd-neurodevelopment-abstract: Teng X, Aouacheria A, Lionnard L, et al. (2019) KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders. CNS Neuroscience & Therapeutics 25(7):887-902. DOI: 10.1111/cns.13156. PMID: 31111690.

• ren-2022-kctd8-habenula-abstract: Ren Y, Liu Y, Zheng S, Luo M. (2022) KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons. Journal of Neuroscience 42(9):1648-1665. DOI: 10.1523/JNEUROSCI.1676-21.2021. PMID: 35017224.

• fritzius-2017-kctd-hetero-oligomers-abstract: Fritzius T, Turecek R, Seddik R, et al. (2017) KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents. Journal of Neuroscience 37(5):1162-1175. DOI: 10.1523/JNEUROSCI.2181-16.2016. PMID: 28003345.

• zhou-2024-kctd8-cancer-abstract: Zhou J, Zhang M, Gao A, Herman JG, Guo M. (2024) Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling. Epigenomics 16(13):929-944. DOI: 10.1080/17501911.2024.2370590. PMID: 39016152.

• turecek-2021-kctd8-cav23-abstract: Turecek R, Fritzius T, Bhumbra SA, Gassmann M, Bettler B. (2021) GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals. eLife 10:e68274. DOI: 10.7554/eLife.68274. PMID: 34018460.

• pinkas-2018-kctd8-h1-structure-summary: Pinkas DM, von Delft F, Arrowsmith CH, Bullock AN. (2018) Structure of the H1 domain of human KCTD8. PDB ID: 6G57. Released 2019-03-20.

• esposito-2022-alphafold-kctd-abstract: Esposito L, Balasco N, Ruggiero A, Berisio R, Vitagliano L. (2022) Alphafold Predictions Provide Insights into the Structural Features of the Functional Oligomers of All Members of the KCTD Family. International Journal of Molecular Sciences 23(21):13346. DOI: 10.3390/ijms232113346.

• paus-2012-kctd8-brain-gwas-abstract: Paus T, Bernard M, Chakravarty MM, et al. (2012) KCTD8 Gene and Brain Growth in Adverse Intrauterine Environment: A Genome-wide Association Study. Cerebral Cortex 22(11):2634-2642. DOI: 10.1093/cercor/bhr350. PMID: 22156575.

Citations

1. esposito-2022-alphafold-kctd-abstract.md
2. fritzius-2017-kctd-hetero-oligomers-abstract.md
3. metz-2011-kctd-distribution-brain-abstract.md
4. paus-2012-kctd8-brain-gwas-abstract.md
5. pinkas-2018-kctd8-h1-structure-summary.md
6. ren-2022-kctd8-habenula-abstract.md
7. schwenk-2010-gabab-kctd-auxiliary-abstract.md
8. schwenk-2010-gabab-kctd-auxiliary-summary.md
9. seddik-2012-kctd-desensitization-abstract.md
10. seddik-2012-kctd-desensitization-summary.md
11. teng-2019-kctd-neurodevelopment-abstract.md
12. turecek-2021-kctd8-cav23-abstract.md
13. zheng-2019-kctd-structural-abstract.md
14. zheng-2019-kctd-structural-summary.md
15. zhou-2024-kctd8-cancer-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: Human KCTD8 (UniProt Q6ZWB6)

Identity verification and core concepts
- Target verified: KCTD8 (BTB/POZ domain-containing protein KCTD8) is a human KCTD-family protein with an N‑terminal BTB/POZ (also termed T1-type) oligomerization domain and C‑terminal homology region(s) found among GABAB auxiliary KCTDs. Foundational brain proteomics identified KCTD8 as a native interactor of GABAB receptors, consolidating its classification as an auxiliary subunit of GABABRs (Homo sapiens orthology inferred across mammalian systems). The BTB/POZ identity of KCTD8 is explicitly documented among native GABAB receptor complexes purified from brain (Nature 2010) (schwenk2010nativegababreceptors pages 13-16). High-resolution studies of KCTD subfamily members (KCTD16, KCTD12) define the shared domain architecture and conserved binding interfaces with GB2 applicable to KCTD8 by sequence and structural conservation (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).

• Family/domain features: GABAB-associated KCTDs (KCTD8/12/12b/16) possess: (1) an N-terminal BTB/T1 oligomerization domain that binds the GABAB2 (GB2) intracellular C-terminus; and (2) a downstream H1 domain that binds Gβγ; KCTD8/KCTD16 additionally retain a distal H2 domain absent in KCTD12/12b, which underlies their distinct desensitization behavior (inferred from structural/functional comparisons across KCTDs) (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).

Primary function and mechanisms
- Role as GABAB receptor auxiliary subunit: Native GABAB receptors are heteromultimers with auxiliary KCTDs; KCTD8 co-purifies with GABAB1/2 from brain, establishing it as part of receptor complexes in situ (Nature 2010; URL: https://doi.org/10.1038/nature08964; published May 13, 2010) (schwenk2010nativegababreceptors pages 13-16).
- Receptor and G protein binding sites: Structural work shows KCTDs form asymmetric pentamers via the BTB domain that wrap around a GB2 C-terminal peptide; the GB2–KCTD interface is conserved across KCTD8/12/16, implying the same mode for KCTD8. The H1 domain symmetrically engages five Gβγ copies, with cooperative binding that underlies kinetic control of signaling (Nature 2019; URL: https://doi.org/10.1038/s41586-019-0990-0; published Feb 27, 2019) (zheng2019structuralbasisfor pages 1-2). The KCTD16–GB2 crystal structure further delineates the BTB pentamer binding a single GB2 CTD peptide, with interface residues conserved among KCTDs and required for GABAB/GIRK modulation (PNAS 2019; URL: https://doi.org/10.1073/pnas.1903024116; published Apr 16, 2019) (zuo2019structuralbasisfor pages 1-1).
- Signaling kinetics and GIRK coupling: KCTD family members shape rise times and desensitization of GABAB-evoked GIRK currents; KCTD proteins bind Gβγ and can rapidly strip G proteins from GIRKs to induce desensitization. KCTD12/12b harbor an H1 desensitization motif, whereas KCTD8 (and KCTD16) lack this motif and thus support comparatively non-desensitizing or slowly desensitizing responses; collectively, KCTD8/12/16 set distinct activation/desensitization kinetics of GIRK and the overall time course of GABAB signaling (Nature 2019) (zheng2019structuralbasisfor pages 1-2). Earlier mechanistic physiology established that KCTD8/12/16 constitutively interact with G proteins to stabilize them at the receptor and accelerate K+ current responses (Neuron 2014; URL: https://doi.org/10.1016/j.neuron.2014.04.015; published Jun 4, 2014) (david2018gababreceptorassociatedkctd pages 14-17).

Subcellular localization and expression patterns
- Presynaptic enrichment in habenula pathway: In mouse medial habenula (MHb) cholinergic neurons projecting to the interpeduncular nucleus (IPN), KCTD8 shows presynaptic active-zone localization with GABAB1 and Cav2.3 channels. Active-zone replica labeling demonstrated KCTD8 presence within Cav2.3/GABAB1-positive zones; genetic perturbations established functional contribution to basal release probability (eLife 2021; URL: https://doi.org/10.7554/eLife.68274; published Apr 14, 2021) (bhandari2021gababreceptorauxiliary pages 9-11). Immunohistochemistry in the same circuit showed strong KCTD8 expression in somata and axonal terminals of ChAT+ habenula neurons (J. Neurosci. 2022; URL: https://doi.org/10.1523/JNEUROSCI.1676-21.2021; published Jan 19, 2022) (ren2022kctd8andkctd12 pages 7-9).
- Axonal GABAB receptor enrichment: Genetic deletion of KCTD8/12/16 (triple KO) reduced axonal GABAB receptor expression in habenular cholinergic terminals without affecting somatic receptors, indicating a role for KCTD8/12 in presynaptic axonal targeting/stability of GABABRs (J. Neurosci. 2022) (ren2022kctd8andkctd12 pages 7-9).

Interactions beyond canonical GABAB coupling
- Cav2.3 channel association: In the MHb→IPN pathway, KCTD8 directly binds Cav2.3 and modulates its currents in heterologous cells; at synapses, KCTD8 co-clusters with Cav2.3 and GABAB1. Functionally, KCTD8 KO decreased basal release probability (WT: 0.26 ± 0.04 vs Kctd8−/−: 0.12 ± 0.02; n = 16 and 12 cells, respectively), whereas KCTD8 overexpression lowered PPR (EGFP: 2.17 ± 0.18 vs LV-KCTD8: 1.41 ± 0.14), consistent with enhanced release probability when KCTD8 is present (eLife 2021) (bhandari2021gababreceptorauxiliary pages 9-11).
- Potential Cul3–E3 ligase linkage (cautious inference): BTB-containing KCTDs often act as substrate adaptors for Cullin3 E3 ubiquitin ligases; family-level evidence strongly supports Cul3 engagement (e.g., KCTD5/Cul3–Gβγ). For KCTD8 specifically, direct Cul3 biochemical evidence remains limited; the domain architecture and family context suggest plausibility that remains to be established experimentally (family overview and mechanistic model in 2018 thesis) (david2018gababreceptorassociatedkctd pages 14-17). Given the lack of direct KCTD8–Cul3 evidence here, this remains an inference rather than a demonstrated property.

Quantitative signaling data (selected)
- Presynaptic GABAB excitation requires KCTD8/12: In MHb cholinergic axons, triple KOs (Kctd8/12/16) showed substantially reduced baclofen-induced potentiation of glutamate release (−67.3% of fold increase vs wild-type) and smaller increases in presynaptic Ca2+ entry (−36.6% vs wild-type), linking KCTD8/12/16 to the magnitude and duration of presynaptic GABAB excitation (J. Neurosci. 2022) (ren2022kctd8andkctd12 pages 7-9).
- Basal release probability and PPR shifts: At MHb terminals, Kctd8−/− reduced release probability to 0.12 ± 0.02 (WT 0.26 ± 0.04), while KCTD8 overexpression decreased PPR from 2.17 ± 0.18 (control) to 1.41 ± 0.14, reflecting increased release probability with KCTD8 (eLife 2021) (bhandari2021gababreceptorauxiliary pages 9-11).

Recent developments and expert analyses (2021–2024 emphasis)
- Structural mechanism generalized to KCTD8: Cryo-EM/X-ray studies (2019) elucidated that KCTD BTB pentamers encircle a GB2 tail and that H1 pentamers bind Gβγ cooperatively, mechanistically explaining accelerated activation and desensitization control. Conservation across KCTD8/12/16 supports application of this mechanism to KCTD8 (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).
- Circuit-specific presynaptic roles: Multiple 2021–2022 studies in the habenulo–interpeduncular pathway uncovered KCTD8’s presynaptic localization and function, including direct Cav2.3 binding, modulation of release probability, and necessity for robust axonal GABAB receptor expression and presynaptic excitation (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).
- Hetero-oligomerization within the KCTD family: KCTD proteins can form hetero-oligomers that confer distinct kinetics to GABAB signaling; while direct KCTD8-containing hetero-oligomer stoichiometries in human tissue remain to be quantified, the KCTD family’s ability to hetero-assemble is supported, with implications for signal diversification (IJMS 2023 review/primary dataset) (liao2023kctd5formsheterooligomeric pages 9-10).

Pathways and cellular context
- GABAB–GIRK axis: KCTD8 modulates GABAB coupling to GIRK channels by binding GB2 and Gβγ. Through cooperative Gβγ engagement, KCTDs regulate GIRK activation kinetics and desensitization. KCTD8’s lack of the canonical desensitization motif (present in KCTD12/12b) positions it toward less desensitizing/slowly desensitizing profiles, extending inhibitory postsynaptic signaling windows relative to KCTD12-driven complexes (Nature 2019) (zheng2019structuralbasisfor pages 1-2).
- Presynaptic Cav2.3 coupling and transmitter release: KCTD8 co-localizes with Cav2.3 at presynaptic active zones and tunes basal release probability and the time course of presynaptic GABAB-mediated facilitation, thereby shaping short-term plasticity in the MHb→IPN circuit (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Disease associations and translational notes
- Neuropsychiatric links via GABAB/KCTD axis: Genetic and functional studies implicate the GABAB–KCTD module in neuropsychiatric phenotypes (e.g., mood disorders associated with KCTD12 and GABAB dysfunction). While direct human genetic associations specific to KCTD8 remain limited in the sources reviewed here, KCTD8 contributes to neural circuit functions (habenula) relevant to aversion and affective behaviors (Nature 2019 for family-level; J. Neurosci. 2022 for circuit-level) (zheng2019structuralbasisfor pages 1-2, ren2022kctd8andkctd12 pages 7-9). Further targeted human genetic studies for KCTD8 are warranted.

Oligomeric state
- KCTD BTB domains assemble into pentamers that scaffold GB2 and Gβγ; although solved for KCTD16, the conserved interfaces and cross-KCTD functional readouts strongly support a KCTD8 pentameric assembly at the receptor (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).

Cellular localization
- Cytosolic/inner membrane face auxiliary protein that associates with the intracellular tail of GB2 at the plasma membrane; enriched at presynaptic active zones in specific circuits (MHb→IPN), and also present in somata of the same cholinergic neurons (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Expert opinions and synthesis
- Structural and functional convergence argues that KCTD8 serves as a timing element for GABAB signaling: its BTB-mediated GB2 binding tethers a KCTD8 pentamer at the receptor, while its H1 domain engages Gβγ to set activation rise times and desensitization. The presence of a distal H2 region and absence of the KCTD12 desensitization motif rationalize KCTD8’s more sustained signaling profile. Circuit studies extend KCTD8’s role from postsynaptic GIRK regulation to presynaptic release control via Cav2.3 coupling and axonal GABAB receptor enrichment, highlighting KCTD8 as a modular regulator of both inhibitory and excitatory outputs downstream of GABABRs (Nature 2019; PNAS 2019; eLife 2021; J. Neurosci. 2022) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1, bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Real-world applications and implementations
- Targeting GB2–KCTD interfaces: The structurally defined GB2–KCTD interface offers a druggable surface for modulating GABAB kinetics selectively (PNAS 2019) (zuo2019structuralbasisfor pages 1-1).
- Circuit-selective modulation: Given KCTD8’s presynaptic enrichment and Cav2.3 interactions in the habenula–IPN pathway, KCTD8 represents a handle for circuit-specific tuning of aversion-related behaviors, with potential relevance to mood and addiction treatments (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Limitations and open questions
- Direct biochemical confirmation of KCTD8–Cul3 binding and ubiquitin E3 activity remains to be established, despite strong family precedent for BTB–Cul3 adaptors; current evidence for KCTD8 is inferential (david2018gababreceptorassociatedkctd pages 14-17).
- Human tissue-level expression atlases and single-cell resolution datasets for KCTD8 were not directly captured in the sources cited here; more comprehensive transcriptomic/proteomic profiling in human brain would refine localization and disease associations.

Key references with URLs and publication dates
- Native GABAB heteromultimers with KCTDs (includes KCTD8): Nature, May 13, 2010. URL: https://doi.org/10.1038/nature08964 (schwenk2010nativegababreceptors pages 13-16).
- Structural mechanism for KCTD-mediated GABAB control (conserved across KCTD8/12/16): Nature, Feb 27, 2019. URL: https://doi.org/10.1038/s41586-019-0990-0 (zheng2019structuralbasisfor pages 1-2).
- GB2–KCTD16 structure defining a druggable interface, conserved features applicable to KCTD8: PNAS, Apr 16, 2019. URL: https://doi.org/10.1073/pnas.1903024116 (zuo2019structuralbasisfor pages 1-1).
- Presynaptic active-zone localization with Cav2.3, quantitative release modulation by KCTD8: eLife, Apr 14, 2021. URL: https://doi.org/10.7554/eLife.68274 (bhandari2021gababreceptorauxiliary pages 9-11).
- KCTD8/12/16 facilitate axonal GABAB receptor expression and presynaptic excitation: Journal of Neuroscience, Jan 19, 2022. URL: https://doi.org/10.1523/JNEUROSCI.1676-21.2021 (ren2022kctd8andkctd12 pages 7-9).
- Mechanistic physiology of KCTD-dependent acceleration/desensitization via G protein stabilization at GABAB: Neuron, Jun 4, 2014. URL: https://doi.org/10.1016/j.neuron.2014.04.015 (david2018gababreceptorassociatedkctd pages 14-17).
- KCTD5 hetero-oligomerization with neuronal KCTDs (family-level heteromers relevant to KCTD8): IJMS, Sep 18, 2023. URL: https://doi.org/10.3390/ijms241814317 (liao2023kctd5formsheterooligomeric pages 9-10).

Conclusion
Human KCTD8 (Q6ZWB6) is a BTB/POZ-domain KCTD that functions as an auxiliary GABAB receptor subunit. Through a conserved BTB-mediated GB2 interaction and H1-mediated cooperative Gβγ binding, it shapes the activation and desensitization kinetics of GABAB signaling, particularly coupling to GIRK. In defined brain circuits, KCTD8 is enriched at presynaptic active zones, binds Cav2.3, and governs basal release probability and the strength/duration of presynaptic GABAB-mediated excitation. Structural frameworks generalize from solved KCTD12/16 complexes to KCTD8 based on conservation, and recent circuit studies position KCTD8 as a tunable node for synaptic and behavioral modulation. Direct evidence for a KCTD8–Cul3 E3 ligase role remains an open area for investigation (schwenk2010nativegababreceptors pages 13-16, zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1, bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9, david2018gababreceptorassociatedkctd pages 14-17, liao2023kctd5formsheterooligomeric pages 9-10).

References

1. (schwenk2010nativegababreceptors pages 13-16): Jochen Schwenk, Michaela Metz, Gerd Zolles, Rostislav Turecek, Thorsten Fritzius, Wolfgang Bildl, Etsuko Tarusawa, Akos Kulik, Andreas Unger, Klara Ivankova, Riad Seddik, Jim Y. Tiao, Mathieu Rajalu, Johana Trojanova, Volker Rohde, Martin Gassmann, Uwe Schulte, Bernd Fakler, and Bernhard Bettler. Native gabab receptors are heteromultimers with a family of auxiliary subunits. Nature, 465:231-235, May 2010. URL: https://doi.org/10.1038/nature08964, doi:10.1038/nature08964. This article has 377 citations and is from a highest quality peer-reviewed journal.

2. (zheng2019structuralbasisfor pages 1-2): Sanduo Zheng, Nohely Abreu, Joshua Levitz, and Andrew C. Kruse. Structural basis for kctd-mediated rapid desensitization of gabab signalling. Nature, 567:127-131, Feb 2019. URL: https://doi.org/10.1038/s41586-019-0990-0, doi:10.1038/s41586-019-0990-0. This article has 97 citations and is from a highest quality peer-reviewed journal.

3. (zuo2019structuralbasisfor pages 1-1): Hao Zuo, Ian Glaaser, Yulin Zhao, Igor Kurinov, Lidia Mosyak, Haonan Wang, Jonathan Liu, Jinseo Park, Aurel Frangaj, Emmanuel Sturchler, Ming Zhou, Patricia McDonald, Yong Geng, Paul A. Slesinger, and Qing R. Fan. Structural basis for auxiliary subunit kctd16 regulation of the gabab receptor. Proceedings of the National Academy of Sciences, 116:8370-8379, Apr 2019. URL: https://doi.org/10.1073/pnas.1903024116, doi:10.1073/pnas.1903024116. This article has 54 citations and is from a highest quality peer-reviewed journal.

4. (david2018gababreceptorassociatedkctd pages 14-17): David Berner. Gabab receptor-associated kctd proteins as molecular linkers to downstream signaling complexes. ArXiv, 2018. URL: https://doi.org/10.5451/unibas-006803142, doi:10.5451/unibas-006803142. This article has 0 citations.

5. (bhandari2021gababreceptorauxiliary pages 9-11): Pradeep Bhandari, David Vandael, Diego Fernández-Fernández, Thorsten Fritzius, David Kleindienst, Cihan Önal, Jacqueline Montanaro, Martin Gassmann, Peter Jonas, Akos Kulik, Bernhard Bettler, Ryuichi Shigemoto, and Peter Koppensteiner. Gabab receptor auxiliary subunits modulate cav2.3-mediated release from medial habenula terminals. eLife, Apr 2021. URL: https://doi.org/10.7554/elife.68274, doi:10.7554/elife.68274. This article has 29 citations and is from a domain leading peer-reviewed journal.

6. (ren2022kctd8andkctd12 pages 7-9): Yuqi Ren, Yang Liu, Sanduo Zheng, and Minmin Luo. Kctd8 and kctd12 facilitate axonal expression of gaba_breceptors in habenula cholinergic neurons. The Journal of Neuroscience, 42:1648-1665, Jan 2022. URL: https://doi.org/10.1523/jneurosci.1676-21.2021, doi:10.1523/jneurosci.1676-21.2021. This article has 11 citations.

7. (liao2023kctd5formsheterooligomeric pages 9-10): Yini Liao, Douglas C. Sloan, Josephine H. Widjaja, and Brian S. Muntean. Kctd5 forms hetero-oligomeric complexes with various members of the kctd protein family. International Journal of Molecular Sciences, 24:14317, Sep 2023. URL: https://doi.org/10.3390/ijms241814317, doi:10.3390/ijms241814317. This article has 9 citations and is from a poor quality or predatory journal.

Citations

1. schwenk2010nativegababreceptors pages 13-16
2. zheng2019structuralbasisfor pages 1-2
3. zuo2019structuralbasisfor pages 1-1
4. david2018gababreceptorassociatedkctd pages 14-17
5. bhandari2021gababreceptorauxiliary pages 9-11
6. https://doi.org/10.1038/nature08964;
7. https://doi.org/10.1038/s41586-019-0990-0;
8. https://doi.org/10.1073/pnas.1903024116;
9. https://doi.org/10.1016/j.neuron.2014.04.015;
10. https://doi.org/10.7554/eLife.68274;
11. https://doi.org/10.1523/JNEUROSCI.1676-21.2021;
12. https://doi.org/10.1038/nature08964
13. https://doi.org/10.1038/s41586-019-0990-0
14. https://doi.org/10.1073/pnas.1903024116
15. https://doi.org/10.7554/eLife.68274
16. https://doi.org/10.1523/JNEUROSCI.1676-21.2021
17. https://doi.org/10.1016/j.neuron.2014.04.015
18. https://doi.org/10.3390/ijms241814317
19. https://doi.org/10.1038/nature08964,
20. https://doi.org/10.1038/s41586-019-0990-0,
21. https://doi.org/10.1073/pnas.1903024116,
22. https://doi.org/10.5451/unibas-006803142,
23. https://doi.org/10.7554/elife.68274,
24. https://doi.org/10.1523/jneurosci.1676-21.2021,
25. https://doi.org/10.3390/ijms241814317,

Overview of KCTD8 (BTB/POZ Domain-Containing Protein KCTD8)

KCTD8 is a human protein (UniProt Q6ZWB6) belonging to the KCTD family – a group of proteins defined by a “potassium channel tetramerization domain” (BTB/POZ domain) in their N-terminus. The KCTD family name reflects structural similarity to the tetramerization (T1) domain of voltage-gated K^+ channels, but KCTD8 itself is not an ion channel. Instead, it functions as an auxiliary (accessory) subunit of the GABA_B (metabotropic GABA type B) receptor, influencing the receptor’s signaling properties (www.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). KCTD8 is one of four KCTD proteins (KCTD8, KCTD12, KCTD12b, and KCTD16) identified in 2010 as additional subunits that assemble with GABA_B receptor complexes (pmc.ncbi.nlm.nih.gov). These auxiliary subunits do not form the receptor’s ligand-binding core, but they attach to the receptor’s intracellular domain and modulate its function (pmc.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). Importantly, the gene KCTD8 is expressed predominantly in the brain (with highest mRNA levels in neural tissues) and to a lesser extent in a few other tissues (e.g. thyroid), consistent with its neuro-specific role (www.ncbi.nlm.nih.gov).

Key structural features: KCTD8 is a relatively large cytosolic protein (~473 amino acids) composed of modular domains characteristic of the KCTD family. Its N-terminal BTB/POZ domain (also called a T1 domain) mediates self-oligomerization and direct binding to the GABA_B2 receptor subunit’s intracellular tail (pubmed.ncbi.nlm.nih.gov). This BTB domain enables KCTD8 to form a homotetramer (four subunits) when associated with the receptor (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Downstream of the BTB domain, KCTD8 contains a conserved H1 domain (with a beta-propeller-like fold) and a unique H2 domain at its C-terminus (pubmed.ncbi.nlm.nih.gov). The presence of the H2 domain distinguishes KCTD8 (and its close relative KCTD16) from KCTD12, which lacks H2 (pubmed.ncbi.nlm.nih.gov). These domains have pivotal functional roles: the BTB (T1) domain anchors KCTD8 to the GABA_B receptor (specifically to the GABA_B2 subunit), while the H1 domain mediates interaction with the G-protein βγ subunits that are coupled to the receptor (www.ncbi.nlm.nih.gov). In KCTD12 (which causes rapid signal desensitization), a specific short motif in the H1 region (T/NFLEQ sequence) is responsible for accelerating GABA_B signal termination (pubmed.ncbi.nlm.nih.gov). KCTD8’s H1 domain lacks this desensitizing motif and instead is followed by the H2 region, which appears to sterically counteract desensitization (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). As a result, KCTD8 does not promote fast desensitization of GABA_B receptor signaling (pubmed.ncbi.nlm.nih.gov). This structural difference underlies the distinct regulatory effects of various KCTDs on the receptor, as discussed below.

Role as a GABA_B Receptor Auxiliary Subunit

Function in GABA_B signaling: KCTD8 is an integral component of certain native GABA_B receptor complexes, where it acts as a non-enzymatic adaptor/regulatory protein influencing GABA_B signal transduction. GABA_B receptors are dimeric G-protein-coupled receptors (GPCRs) for the inhibitory neurotransmitter GABA, and when activated they engage Gi/o-type heterotrimeric G-proteins. The GABA_B heterodimer consists of principal subunits GABA_B1 (ligand-binding) and GABA_B2 (G-protein coupling); KCTD8 attaches to the intracellular domain of GABA_B2 (pubmed.ncbi.nlm.nih.gov). Once bound, KCTD8 helps determine the kinetics and pharmacological profile of the receptor’s response (www.ncbi.nlm.nih.gov). Notably, KCTD8 confers a largely non-desensitizing response to prolonged GABA stimulation (pubmed.ncbi.nlm.nih.gov). In electrophysiological terms, when KCTD8 is part of the GABA_B receptor complex, the downstream G-protein-activated K^+ current (e.g., GIRK channel current that causes neuronal hyperpolarization) remains sustained during continuous agonist presence, with minimal rundown (pubmed.ncbi.nlm.nih.gov). This contrasts with complexes containing KCTD12, which show rapid and pronounced desensitization (a quick decrease of current despite continued agonist) (pubmed.ncbi.nlm.nih.gov). Empirical studies demonstrated these differences: for example, Schwenk et al. (2010) found that KCTD8- or KCTD16-associated GABA_B receptors produce sustained (non-desensitizing) inhibitory currents, whereas KCTD12 produces strong desensitization of the current (pubmed.ncbi.nlm.nih.gov). The mechanistic basis was later elucidated – KCTD8’s H1 domain can bind G-protein βγ subunits without inducing the rapid disengagement that KCTD12 triggers (www.ncbi.nlm.nih.gov). Furthermore, the extra H2 domain in KCTD8 appears to hinder the desensitizing action that an H1 domain alone might have, effectively acting as a brake on signal termination (pubmed.ncbi.nlm.nih.gov). In experiments swapping domains between KCTD subunits, the H2 region of KCTD8/16 was found to suppress desensitization in a steric, sequence-independent manner (when appended to a desensitizing H1) (pubmed.ncbi.nlm.nih.gov). Thus, KCTD8-containing receptor complexes transmit a more persistent inhibitory signal, which may be important for certain physiological contexts requiring sustained GABA_B activity.

Auxiliary subunit assembly and signaling: KCTD8 (like other KCTDs in this family) functions as a tetramer bound to the cytosolic tail of the GABA_B receptor. Cryo-EM and biochemical analyses indicate one GABA_B heterodimer can associate with a homotetramer of KCTD subunits (pubmed.ncbi.nlm.nih.gov). Within this complex, KCTD8 not only contacts the receptor but also is positioned to interact with the G-protein. Indeed, biophysical studies using energy transfer assays showed that KCTD subunits bind both the GABA_B receptor and the G-protein simultaneously (pmc.ncbi.nlm.nih.gov). KCTD8’s interaction with the G-protein βγ subunits likely modulates the coupling efficiency to downstream effectors (such as GIRK K^+ channels or neuronal Ca^2+ channels). One model is that KCTD8 acts as a molecular scaffold that pre-associates with G_βγ, keeping it available at the receptor for sustained signaling, whereas KCTD12 acts more like a sink or modulator that promotes G_βγ re-sequestration (hastening signal termination) (www.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Supporting this, structural data from related KCTDs show the H1 domain directly contacts G_βγ (www.ncbi.nlm.nih.gov). Functionally, the presence of KCTD8 has little effect on the initial activation of GABA_B signaling (onset of the K^+ current) but significantly affects the duration and termination of the response (pubmed.ncbi.nlm.nih.gov). KCTD8-associated signals decay slowly (non-desensitizing), whereas KCTD12-associated signals decay rapidly; KCTD16 (the other H2-containing subunit) produces an intermediate-sustained profile (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). These auxiliary subunits thus create distinct receptor subtypes with different signaling kinetics (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). It’s important to note that KCTD8 itself is not an enzyme or channel – it does not catalyze reactions or directly conduct ions. Instead, its primary function is regulatory and scaffolding, fine-tuning the GABA_B receptor’s communication with intracellular signaling pathways (G-proteins and ion channels).

Expression Pattern and Cellular Localization

Tissue and cellular expression: Consistent with its role in synaptic signaling, KCTD8 is predominantly expressed in the central nervous system. In mice, Kctd8 mRNA is enriched in specific brain regions and neuron populations, with a more restricted expression pattern compared to the broadly expressed KCTD12 and KCTD16 (pubmed.ncbi.nlm.nih.gov). In situ hybridization mapping of the mouse brain showed that KCTD12 and KCTD16 transcripts are widespread, whereas KCTD8 (and the related KCTD12b) are confined to more limited regions or subsets of neurons (pubmed.ncbi.nlm.nih.gov). For example, certain cerebellar neurons or habenular neurons preferentially express KCTD8 or KCTD12, but not both, suggesting cell-type specificity in auxiliary subunit usage (pubmed.ncbi.nlm.nih.gov). Many neurons co-express at least one KCTD family member: most neurons in the brain have some KCTD expression, implying that the majority of native GABA_B receptors incorporate an auxiliary subunit (pubmed.ncbi.nlm.nih.gov). However, the exact KCTD isoform can vary by brain region and developmental stage (pubmed.ncbi.nlm.nih.gov). In the adult rodent hippocampus, for instance, principal cells co-express KCTD12 and KCTD16 (which can form heteromeric complexes; see below), whereas in the cerebellum certain neurons might express only KCTD8 or only KCTD16 at a time (pubmed.ncbi.nlm.nih.gov). Human expression data also indicate KCTD8 is brain-biased, with lower expression in peripheral tissues (a notable exception being the thyroid gland, where moderate KCTD8 expression is reported, though the functional significance there is unclear) (www.ncbi.nlm.nih.gov).

Subcellular localization: As a soluble intracellular protein that binds membrane receptors, KCTD8 is found at the cytoplasmic face of the plasma membrane in cells where it partners with GABA_B receptors. It has no transmembrane region of its own, but co-localizes with GABA_B receptors at synaptic sites. Interestingly, different KCTD family members show distinct subcellular targeting within neurons – some concentrate at dendritic postsynaptic sites, others in axonal or presynaptic compartments (pubmed.ncbi.nlm.nih.gov). KCTD8 appears to have a propensity for axonal/presynaptic localization in certain neurons. A recent study of habenula–interpeduncular pathway neurons (a circuit involved in aversive memory) found that KCTD8 (along with KCTD12) is crucial for enriching GABA_B receptors in axon terminals of those neurons (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In that context, KCTD8 helps traffic or stabilize GABA_B receptors at presynaptic release sites. When KCTD8 and KCTD12 were genetically knocked out in mice, GABA_B receptors were significantly reduced at the axon terminals (but not in the neuron cell bodies), indicating these subunits facilitate receptor transport or retention in axons (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Correspondingly, the absence of KCTD8/12 greatly dampened GABA_B-mediated presynaptic effects – specifically, the normal GABA_B-dependent enhancement of glutamate release (an atypical excitatory action of GABA_B in the habenula circuit) was lost in KCTD8/12 knockouts (pmc.ncbi.nlm.nih.gov). Overexpressing KCTD8 in the knockout neurons could restore GABA_B levels at terminals and rescue the functional effect (pmc.ncbi.nlm.nih.gov). These results suggest KCTD8 not only modulates GABA_B signaling kinetics but also can influence receptor localization and presynaptic signaling strength in certain pathways. In general, KCTD8 is thought to localize wherever its bound GABA_B2 receptor localizes – this can include postsynaptic densities (on dendritic membranes responding to GABA release) or presynaptic membranes (when GABA_B acts as an autoreceptor/modulator on axon terminals). The exact distribution of KCTD8 between pre- vs. postsynaptic compartments likely varies by neuron type. Immunohistochemical studies support that different KCTDs can show distinct axonal or dendritic enrichment in vivo (pubmed.ncbi.nlm.nih.gov), which aligns with the specialized roles (e.g., KCTD8 in presynaptic regulation as seen in habenular neurons).

Oligomerization and Functional Diversity

One important aspect of KCTD8 and its relatives is their ability to form hetero-oligomeric complexes. While KCTD8 typically forms homotetramers, it can also co-assemble with other KCTD subunits if they are co-expressed in the same cell. Research has shown that different KCTD family members can mix, creating heteromeric tetramers with varied subunit composition (pmc.ncbi.nlm.nih.gov). For example, in hippocampal neurons that express both KCTD12 and KCTD16, a significant fraction of KCTD subunits are assembled as KCTD12–KCTD16 heteromers rather than exclusively homomers (pmc.ncbi.nlm.nih.gov). Although KCTD8 was not as widely distributed in those hippocampal cells, it is closely related to KCTD16 and can potentially hetero-oligomerize with KCTD16 or KCTD12 when co-expressed (www.mdpi.com) (www.mdpi.com). In vitro co-immunoprecipitation and bioluminescence energy transfer experiments have confirmed that KCTD8 can interact and form complexes with KCTD16 (and to some extent with other KCTDs) (www.mdpi.com) (www.mdpi.com). On the other hand, some pairings are unfavorable (e.g., KCTD8 did not strongly co-assemble with KCTD5’s BTB domain alone, indicating the C-terminal regions mediate certain specific interactions) (www.mdpi.com) (www.mdpi.com). The functional consequence of heteromeric assembly is an expanded range of receptor signaling behaviors. Hetero-tetramers composed of a mix of desensitizing and non-desensitizing subunits exhibit intermediate kinetics not seen with any single subunit type alone (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For instance, a KCTD12/KCTD16 hybrid tetramer produces GABA_B-activated K^+ currents that desensitize moderately and deactivate at a faster rate than KCTD16 alone but slower than KCTD12 alone (pmc.ncbi.nlm.nih.gov). In other words, co-assembly of distinct KCTDs “tunes” the receptor signaling to intermediate levels, providing a fine gradation of inhibitory signaling responses. Bettler and colleagues (2017) demonstrated that mixed KCTD complexes increase the functional repertoire of native GABA_B receptors, allowing neurons to customize the duration and strength of their slow inhibitory postsynaptic currents (IPSCs) (pmc.ncbi.nlm.nih.gov). This combinatorial assembly is likely relevant in brain regions where multiple KCTDs are co-expressed (e.g., hippocampus, cortex), but less so in regions with only one KCTD isoform. In summary, KCTD8 can function both as a homotetrameric regulator and potentially as part of heteromeric KCTD assemblies, giving it the flexibility to contribute to various kinetic profiles of GABA_B signaling. Such versatility underscores a broader principle: simultaneous assembly of distinct KCTD subunits at the receptor increases the molecular and functional diversity of GABA_B receptor signaling (pmc.ncbi.nlm.nih.gov).

It’s also notable that KCTD8 and its family do not universally share all functions of BTB-domain proteins. Many BTB/POZ domain proteins serve as adaptors for Cullin-3 ubiquitin ligase complexes, targeting specific proteins for proteasomal degradation. Some KCTDs (e.g., KCTD11, KCTD6, KCTD5) bind Cullin-3 and function as substrate adaptors in ubiquitination pathways (pmc.ncbi.nlm.nih.gov). However, KCTD8 (along with KCTD12 and KCTD16 in the same clade) has lost the ability to bind Cullin-3 (pmc.ncbi.nlm.nih.gov). Despite the high sequence similarity in the BTB domains, subtle differences (such as in the BTB loop regions) prevent Cullin-3 interaction in these neuronal KCTDs (pmc.ncbi.nlm.nih.gov). Indeed, biochemical assays have shown that clade F KCTDs (KCTD8/12/16) do not recruit Cullin-3, emphasizing that their role is cullin-independent (pmc.ncbi.nlm.nih.gov). This evolutionary divergence likely reflects specialization – instead of participating in ubiquitin ligase complexes, KCTD8 specializes in protein–protein interactions at neurotransmitter receptors. Thus, KCTD8 acts as a signaling adaptor rather than a ubiquitination adaptor, distinguishing its function from some other members of the BTB protein superfamily.

Biological Processes and Pathways Involving KCTD8

Inhibitory neurotransmission: The primary biological process involving KCTD8 is GABAergic inhibitory neurotransmission in the brain. By modulating GABA_B receptor function, KCTD8 influences the slow inhibitory postsynaptic potentials that shape neuronal excitability. GABA_B receptors, when activated (for instance, by synaptically released GABA or pharmacological agonists like baclofen), trigger Gi/o proteins that lead to opening of GIRK (Kir3) potassium channels and inhibition of voltage-gated Ca^2+ channels. These events result in neuronal hyperpolarization and reduced transmitter release, respectively. KCTD8’s role in this pathway is to alter the temporal dynamics of the GABA_B signal – essentially controlling how long and how steady the GABA_B effect persists. In cells expressing KCTD8, GABA_B activation produces a more prolonged inhibitory effect (due to sustained GIRK currents), which can significantly impact network activity such as oscillatory rhythms or synaptic integration over seconds (pubmed.ncbi.nlm.nih.gov). In contrast, cells with KCTD12 experience a quicker fade of the inhibitory effect, potentially allowing faster recovery from inhibition. Therefore, KCTD8 is implicated in maintaining prolonged inhibition in neural circuits, which could be crucial for processes like spike timing regulation, synaptic plasticity (if prolonged hyperpolarization gates plasticity windows), or neurophysiological phenomena like slow-wave oscillations.

Synaptic localization and plasticity: The discovery that KCTD8 helps localize GABA_B receptors to axon terminals in habenular cholinergic neurons (pmc.ncbi.nlm.nih.gov) sheds light on its role in presynaptic modulation. In the medial habenula–interpeduncular nucleus pathway, GABA_B receptors have an unconventional excitatory effect – they enhance presynaptic glutamate release, thereby increasing excitation of target neurons (pmc.ncbi.nlm.nih.gov). KCTD8 (with KCTD12) was found to be required for this effect: without these auxiliary subunits, the GABA_B receptors failed to efficiently populate the presynaptic sites and could not facilitate glutamate release (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This indicates KCTD8 participates in neurotransmitter release modulation and synaptic plasticity. Behaviorally, mice lacking KCTD8/12 in that circuit showed altered aversive memory processing – specifically, stronger activation of the downstream nucleus and impaired extinction of fear memories, presumably because the GABA_B-mediated presynaptic regulation was weakened (pmc.ncbi.nlm.nih.gov). These findings connect KCTD8 to aversive learning pathways and suggest it has a role in modulating synaptic strength and neural network activity underlying certain behaviors. Although this is one specialized circuit, it exemplifies how KCTD8 can influence higher-order processes (memory, emotion) via its control of GABA_B receptor localization and signaling. It is reasonable to suspect that in other brain regions, KCTD8 might similarly affect how GABA_B receptors contribute to synaptic plasticity, neuronal oscillations, or network excitability – topics that are active areas of neuroscience research.

Pharmacological and therapeutic context: KCTD8’s influence on GABA_B receptor pharmacology is also noteworthy. By “determining the pharmacology” of the receptor response (www.ncbi.nlm.nih.gov), KCTD8 can affect how receptors respond to agonists or allosteric modulators. Experiments have shown that auxiliary subunits can slightly shift potency or efficacy of GABA_B agonists and alter the profile of allosteric modulator drugs (www.ncbi.nlm.nih.gov). This means that drugs targeting GABA_B receptors (used for muscle spasticity, pain, addiction, etc.) might have variable effects depending on which KCTD isoforms are present. As such, understanding KCTD8 distribution could inform pharmacotherapy – for instance, brain regions with KCTD8 may experience more sustained GABA_B-mediated drug effects. From a drug development perspective, the unique interfaces between KCTD8 and the GABA_B receptor or G-protein present potential targets for novel modulators. A 2016 authoritative review noted that the complex protein architecture of GABA_B receptors (including accessory subunits like KCTDs) offers new opportunities for therapeutic intervention in neurological and psychiatric disorders (www.nature.com). In principle, one could envision small molecules that disrupt or enhance KCTD8–receptor interaction, thereby prolonging or shortening GABA_B signals in specific circuits as a therapeutic strategy (though no such drug exists yet). Thus, KCTD8 sits at the intersection of basic neuroscience and potential clinical relevance, as part of the broader effort to fine-tune GABAergic signaling in disease contexts.

Emerging Research and Broader Implications

While KCTD8 is best known for its role in the nervous system, recent studies suggest it may have broader biological significance, including in contexts outside classical GABA_B signaling. Remarkably, KCTD8 has emerged in cancer research as a putative tumor suppressor: a 2024 study reported that KCTD8 is frequently silenced by DNA methylation in hepatocellular carcinoma (HCC) (pmc.ncbi.nlm.nih.gov). Approximately 45% of human HCC tumor samples showed hypermethylation of the KCTD8 gene, correlating with reduced KCTD8 expression (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This epigenetic loss of KCTD8 was associated with enhanced activation of the PI3K–AKT signaling pathway in the cancer cells and more aggressive tumor growth (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Functional assays confirmed that restoring KCTD8 expression in HCC cells suppressed their growth in vitro and in mouse xenografts, by attenuating PI3K/AKT signaling (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The study identified KCTD8 as a novel tumor-suppressive factor in liver cancer, and its methylation status was proposed as an independent poor prognostic biomarker for HCC patients (pmc.ncbi.nlm.nih.gov). This finding expands the relevance of KCTD8 beyond neuroscience, suggesting it interacts with cell-signaling networks like PI3K/AKT. The mechanism is still being uncovered – KCTD8 was found to bind IMPDH2 (inosine monophosphate dehydrogenase 2) in HCC cells, an enzyme that can influence nucleotide pools and is linked to PI3K signaling, hinting that KCTD8 might normally restrain proliferative signaling via protein–protein interactions outside the nervous system (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In summary, loss of KCTD8 removes a brake on PI3K–AKT pathway activity in liver cells, thereby promoting cancer cell survival and proliferation (pmc.ncbi.nlm.nih.gov). This unexpected role in cancer biology underscores that KCTD8’s “auxiliary” functions may extend to other receptors or signaling proteins beyond GABA_B, although GABA_B itself is not thought to play a role in liver physiology.

Additionally, KCTD8 (and other KCTDs) have been detected in certain non-neuronal tissues and contexts, implying potential roles that are not yet well-characterized (pubmed.ncbi.nlm.nih.gov). For instance, KCTD proteins have been found in some immune or endocrine tissues where GABA_B receptors are minimally expressed, raising the possibility that they might partner with different signaling proteins or have scaffolding roles in protein complexes unrelated to neurotransmission (pubmed.ncbi.nlm.nih.gov). KCTD15, another family member, inhibits a transcription factor (AP-2α) during embryonic development (pmc.ncbi.nlm.nih.gov), showing that KCTDs can operate in the nucleus as well. While no direct evidence yet places KCTD8 in such a role, these examples encourage a broader view: KCTD8 might have “moonlighting” functions in cellular pathways beyond synapses. Its proven interaction with IMPDH2 in cancer cells is one clue that KCTD8 can engage in protein networks regulating cell metabolism or growth. Future research may uncover whether KCTD8 influences other GPCRs or signaling complexes, or whether it partakes in ubiquitin-independent protein regulation in different cell types.

Clinical and research implications: Understanding KCTD8’s function has implications for neurological disorders. KCTD12 (an auxiliary subunit of the same family) has been linked to psychiatric conditions – for example, KCTD12 gene variants and expression changes are associated with mood disorders and schizophrenia in some studies (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), and Kctd12-knockout mice exhibit antidepressant-like behavior changes (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). While KCTD8 has not been as directly implicated in human neurological disorders yet, its involvement in the habenular pathway hints at a possible role in disorders of aversive behavior (such as addiction or depression, where habenula circuitry is often dysregulated). The fact that knockout of KCTD8/12 altered fear memory extinction in mice suggests that modulating KCTD8 function could potentially affect anxiety or post-traumatic stress disorder (though this remains speculative). On the oncology side, if the findings in HCC are corroborated, KCTD8 methylation might serve as a biomarker for cancer prognosis, and demethylating agents or gene therapies could be explored to restore its expression in tumors. More immediately, the HCC study positions KCTD8 as a part of the PI3K/AKT regulatory axis, opening new questions about whether KCTD8 polymorphisms or expression changes occur in other cancers or metabolic diseases.

From an expert perspective, the discovery of KCTD8 and related subunits has fundamentally expanded our understanding of GABA_B receptor function. Receptor complexes are now seen as modular assemblies, where core subunits provide baseline function and auxiliary subunits (like KCTD8) fine-tune signaling properties (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). As noted by Bettler and colleagues, this added molecular complexity endows inhibitory synapses with a richer repertoire of responses and plasticity, which can be exploited for more targeted interventions (pmc.ncbi.nlm.nih.gov). In sum, KCTD8 is a BTB-domain adaptor that specializes in regulating GABA_B G-protein signaling – prolonging inhibitory signals and aiding receptor trafficking – and it may also play unanticipated roles in cell signaling, as evidenced by recent cancer research. Continuing studies (especially those published in 2023–2024) highlight KCTD8’s multifaceted importance: in the brain, it helps shape synaptic inhibition and behavior, and beyond the brain, it might act as a tumor suppressor and signaling regulator. Such insights underscore the potential of KCTD8 as a target for research in both neuroscience and disease contexts, warranting further investigation into its molecular partners and regulatory mechanisms.

References:

• Schwenk et al., 2010 – Nature 465: 231–235. (Discovery of KCTD8/12/16 as native GABA_B receptor subunits) (pmc.ncbi.nlm.nih.gov).
• Bartoi et al., 2010 – J. Biol. Chem. 285: 20625–20633. (Proteomic confirmation of KCTD subunits in GABA_B receptor complexes) (pmc.ncbi.nlm.nih.gov).
• Tureček et al., 2013 – J. Biol. Chem. 288: 36341–36355. (Kinetics of GABA_B signaling regulated by KCTD domains; identified H1 motif governing desensitization) (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov).
• Fritzius et al., 2017 – J. Neurosci. 37(5): 1162–1175. (Evidence for KCTD hetero-oligomers (e.g. KCTD12/KCTD16) and their unique effects on GABA_B receptor kinetics) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Mao et al., 2022 – J. Neurosci. 42(9): 1648–1665. (Role of KCTD8/12 in axonal GABA_B receptor expression and presynaptic excitation in habenula; impact on aversive memory) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Zhou et al., 2024 – Epigenomics 16(13): 929–944. (KCTD8 is frequently silenced by DNA methylation in HCC; loss of KCTD8 elevates PI3K/AKT signaling and tumor growth – identification of KCTD8 as a tumor suppressor) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Liao et al., 2023 – Int. J. Mol. Sci. 24(18): 14317. (Analysis of KCTD5 interactions; showed KCTD5 can hetero-oligomerize with KCTD8 and KCTD16, illustrating cross-talk among KCTD family members) (www.mdpi.com) (www.mdpi.com).
• Pin & Bettler, 2016 – Nature 540: 60–68. (Review on mGlu and GABA_B receptor complexes; discusses auxiliary proteins and therapeutic prospects) (www.nature.com).
• Smaldone et al., 2015 – PLoS ONE 10(5): e0126808. (Study on Cullin3 binding across KCTD family; found KCTD8/12/16 do not bind Cullin3, indicating their functions are cullin-independent) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Metz et al., 2011 – J. Comp. Neurol. 519: 1435–1454. (Mapping of KCTD8, 12, 12b, 16 expression in mouse brain; distinct regional and developmental expression patterns, with KCTD8 being more restricted) (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov).

Citations

1. AnnotationURLCitation(end_index=747, start_index=577, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
2. AnnotationURLCitation(end_index=903, start_index=748, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
3. AnnotationURLCitation(end_index=1165, start_index=1064, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=,Google%20Scholar')
4. AnnotationURLCitation(end_index=1422, start_index=1321, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=,Google%20Scholar')
5. AnnotationURLCitation(end_index=1593, start_index=1423, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
6. AnnotationURLCitation(end_index=1973, start_index=1812, title='KCTD8 potassium channel tetramerization domain containing 8 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/386617#:~:text=Expression%20Biased%20expression%20in%20brain,other%20tissues%20See%20more%20Orthologs')
7. AnnotationURLCitation(end_index=2410, start_index=2296, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=are%20unknown,Here%20we%20addressed')
8. AnnotationURLCitation(end_index=2649, start_index=2519, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=GABA,comprising%20a%20T1%20tetramerization%20domain')
9. AnnotationURLCitation(end_index=2805, start_index=2650, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
10. AnnotationURLCitation(end_index=3071, start_index=2957, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=are%20unknown,Here%20we%20addressed')
11. AnnotationURLCitation(end_index=3297, start_index=3183, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=are%20unknown,Here%20we%20addressed')
12. AnnotationURLCitation(end_index=3723, start_index=3553, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
13. AnnotationURLCitation(end_index=4045, start_index=3897, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=auxiliary%20subunits%20constitute%20receptor%20subtypes,12b%20mediate')
14. AnnotationURLCitation(end_index=4331, start_index=4197, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=which%20binds%20to%20GABA,to%20the%20H1%20domains%20but')
15. AnnotationURLCitation(end_index=4477, start_index=4332, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=the%20receptor%20response,and%20acquisition%20of%20the%20T%2FNFLEQ')
16. AnnotationURLCitation(end_index=4724, start_index=4569, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
17. AnnotationURLCitation(end_index=5579, start_index=5465, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=are%20unknown,Here%20we%20addressed')
18. AnnotationURLCitation(end_index=5857, start_index=5687, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
19. AnnotationURLCitation(end_index=6108, start_index=5953, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
20. AnnotationURLCitation(end_index=6541, start_index=6386, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
21. AnnotationURLCitation(end_index=6851, start_index=6696, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
22. AnnotationURLCitation(end_index=7276, start_index=7121, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
23. AnnotationURLCitation(end_index=7608, start_index=7438, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
24. AnnotationURLCitation(end_index=7932, start_index=7787, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=the%20receptor%20response,and%20acquisition%20of%20the%20T%2FNFLEQ')
25. AnnotationURLCitation(end_index=8281, start_index=8136, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=the%20receptor%20response,and%20acquisition%20of%20the%20T%2FNFLEQ')
26. AnnotationURLCitation(end_index=8879, start_index=8749, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=GABA,comprising%20a%20T1%20tetramerization%20domain')
27. AnnotationURLCitation(end_index=9308, start_index=9144, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=reveal%20that%20KCTD12%2FKCTD16%20hetero,one%20min%29%20KCTD12%2FKCTD16%20hetero')
28. AnnotationURLCitation(end_index=9919, start_index=9749, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
29. AnnotationURLCitation(end_index=10054, start_index=9920, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=which%20binds%20to%20GABA,to%20the%20H1%20domains%20but')
30. AnnotationURLCitation(end_index=10320, start_index=10150, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
31. AnnotationURLCitation(end_index=10672, start_index=10524, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=auxiliary%20subunits%20constitute%20receptor%20subtypes,12b%20mediate')
32. AnnotationURLCitation(end_index=11014, start_index=10866, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=auxiliary%20subunits%20constitute%20receptor%20subtypes,12b%20mediate')
33. AnnotationURLCitation(end_index=11170, start_index=11015, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
34. AnnotationURLCitation(end_index=11404, start_index=11274, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=GABA,comprising%20a%20T1%20tetramerization%20domain')
35. AnnotationURLCitation(end_index=11560, start_index=11405, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
36. AnnotationURLCitation(end_index=12403, start_index=12259, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=the%20KCTDs%20in%20the%20mouse,KCTD8%20and%2012b%20a%20restricted')
37. AnnotationURLCitation(end_index=12759, start_index=12615, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=the%20KCTDs%20in%20the%20mouse,KCTD8%20and%2012b%20a%20restricted')
38. AnnotationURLCitation(end_index=13086, start_index=12936, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=brain%2C%20KCTD12%20and%2016%20have,suggesting%20that%20the%20role%20of')
39. AnnotationURLCitation(end_index=13433, start_index=13289, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=the%20KCTDs%20in%20the%20mouse,KCTD8%20and%2012b%20a%20restricted')
40. AnnotationURLCitation(end_index=13673, start_index=13516, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=brain%2C%20KCTD12%20and%2016%20have,In%20summary%2C%20our%20findings%20support')
41. AnnotationURLCitation(end_index=14060, start_index=13910, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=brain%2C%20KCTD12%20and%2016%20have,suggesting%20that%20the%20role%20of')
42. AnnotationURLCitation(end_index=14474, start_index=14313, title='KCTD8 potassium channel tetramerization domain containing 8 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/386617#:~:text=Expression%20Biased%20expression%20in%20brain,other%20tissues%20See%20more%20Orthologs')
43. AnnotationURLCitation(end_index=15138, start_index=14983, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=selectively%20express%20one%20KCTD%20at,We%20propose%20that%20the%20distinct')
44. AnnotationURLCitation(end_index=15613, start_index=15452, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=remains%20unclear%20whether%20and%20how,a%20significant%20decrease%20in%20the')
45. AnnotationURLCitation(end_index=15732, start_index=15614, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=GABA_,related%20memory%20processes')
46. AnnotationURLCitation(end_index=16237, start_index=16076, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=remains%20unclear%20whether%20and%20how,a%20significant%20decrease%20in%20the')
47. AnnotationURLCitation(end_index=16356, start_index=16238, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=GABA_,related%20memory%20processes')
48. AnnotationURLCitation(end_index=16791, start_index=16630, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=remains%20unclear%20whether%20and%20how,a%20significant%20decrease%20in%20the')
49. AnnotationURLCitation(end_index=17099, start_index=16912, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=within%20the%20habenulo%E2%80%93interpeduncular%20pathway%20in,proteins%20in%20enriching%20the%20axonal')
50. AnnotationURLCitation(end_index=17938, start_index=17783, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=selectively%20express%20one%20KCTD%20at,We%20propose%20that%20the%20distinct')
51. AnnotationURLCitation(end_index=18626, start_index=18469, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=duration%20of%20slow%20IPSCs,current%20responses%20in%20the%20hippocampus')
52. AnnotationURLCitation(end_index=18984, start_index=18816, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=receptors%20also%20associate%20with%20hetero,one%20min%29%20KCTD12%2FKCTD16%20hetero')
53. AnnotationURLCitation(end_index=19314, start_index=19170, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=KCTD8%20and%20KCTD16%20also%20interacted,also%20yielded%20a%20BRET%20signal')
54. AnnotationURLCitation(end_index=19464, start_index=19315, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=consisting%20of%20KCTD8%2C%20KCTD12%2C%20and,oligomeric%20configurations%20%5B14')
55. AnnotationURLCitation(end_index=19802, start_index=19658, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=KCTD8%20and%20KCTD16%20also%20interacted,also%20yielded%20a%20BRET%20signal')
56. AnnotationURLCitation(end_index=19942, start_index=19803, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=involved%20in%20shaping%20GABA_,Nluc%2C%20and%20the%20strongest%20with')
57. AnnotationURLCitation(end_index=20281, start_index=20139, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=KCTD16%20but%20not%20with%20KCTD12,Nluc%2C%20and%20the%20strongest%20with')
58. AnnotationURLCitation(end_index=20428, start_index=20282, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=with%20KCTD8%2C%20KCTD12%2C%20and%20KCTD16,luminescence%20experiments.%20Thus')
59. AnnotationURLCitation(end_index=20860, start_index=20696, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=reveal%20that%20KCTD12%2FKCTD16%20hetero,one%20min%29%20KCTD12%2FKCTD16%20hetero')
60. AnnotationURLCitation(end_index=21018, start_index=20861, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=duration%20of%20slow%20IPSCs,current%20responses%20in%20the%20hippocampus')
61. AnnotationURLCitation(end_index=21384, start_index=21220, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=reveal%20that%20KCTD12%2FKCTD16%20hetero,one%20min%29%20KCTD12%2FKCTD16%20hetero')
62. AnnotationURLCitation(end_index=21957, start_index=21800, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=duration%20of%20slow%20IPSCs,current%20responses%20in%20the%20hippocampus')
63. AnnotationURLCitation(end_index=22709, start_index=22552, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=duration%20of%20slow%20IPSCs,current%20responses%20in%20the%20hippocampus')
64. AnnotationURLCitation(end_index=23226, start_index=23084, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=and%20F%20,the%20extensive%20literature%20functional%20and')
65. AnnotationURLCitation(end_index=23470, start_index=23334, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=Taking%20into%20account%20the%20close,and%20of%20the')
66. AnnotationURLCitation(end_index=23771, start_index=23635, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=Taking%20into%20account%20the%20close,and%20of%20the')
67. AnnotationURLCitation(end_index=24069, start_index=23927, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=and%20F%20,the%20extensive%20literature%20functional%20and')
68. AnnotationURLCitation(end_index=25673, start_index=25518, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=properties.%20KCTD12%20and%20,comprising%20a%20T1%20tetramerization%20domain')
69. AnnotationURLCitation(end_index=26423, start_index=26262, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=remains%20unclear%20whether%20and%20how,a%20significant%20decrease%20in%20the')
70. AnnotationURLCitation(end_index=26826, start_index=26691, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=GABA_,potentiation%20of%20glutamate%20release%20and')
71. AnnotationURLCitation(end_index=27202, start_index=27041, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=remains%20unclear%20whether%20and%20how,a%20significant%20decrease%20in%20the')
72. AnnotationURLCitation(end_index=27321, start_index=27203, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=GABA_,related%20memory%20processes')
73. AnnotationURLCitation(end_index=27849, start_index=27698, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=reversed%20the%20changes%20in%20axonal,related%20memory%20processes')
74. AnnotationURLCitation(end_index=28810, start_index=28640, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
75. AnnotationURLCitation(end_index=29218, start_index=29048, title='CDD Conserved Protein Domain Family: H1_KCTD8', type='url_citation', url='https://www.ncbi.nlm.nih.gov/Structure/cdd/cd22218#:~:text=protein%2C%20is%20an%20auxiliary%20subunit,not%20be%20involved%20in%20desensitization')
76. AnnotationURLCitation(end_index=30124, start_index=29963, title='Organization and functions of mGlu and GABAB receptor complexes | Nature', type='url_citation', url='https://www.nature.com/articles/nature20566#:~:text=that%20the%20molecular%20complexity%20of,mental%20health%20and%20neurological%20disorders')
77. AnnotationURLCitation(end_index=31064, start_index=30970, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=,in%20HCC')
78. AnnotationURLCitation(end_index=31376, start_index=31202, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=Results%3A%20KCTD8%20was%20methylated%20in,vivo%20via%20inhibiting%20PI3K%2FAKT%20pathway')
79. AnnotationURLCitation(end_index=31471, start_index=31377, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=,in%20HCC')
80. AnnotationURLCitation(end_index=31804, start_index=31630, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=Results%3A%20KCTD8%20was%20methylated%20in,vivo%20via%20inhibiting%20PI3K%2FAKT%20pathway')
81. AnnotationURLCitation(end_index=31899, start_index=31805, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=,in%20HCC')
82. AnnotationURLCitation(end_index=32244, start_index=32070, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=Results%3A%20KCTD8%20was%20methylated%20in,vivo%20via%20inhibiting%20PI3K%2FAKT%20pathway')
83. AnnotationURLCitation(end_index=32339, start_index=32245, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=,in%20HCC')
84. AnnotationURLCitation(end_index=32620, start_index=32526, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=,in%20HCC')
85. AnnotationURLCitation(end_index=33249, start_index=33091, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=The%20mechanism%20of%20KCTD8%20in,by%20the%20KCTD8%20antibody%2C%20IMPDH2')
86. AnnotationURLCitation(end_index=33406, start_index=33250, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=employed%20to%20clarify%20the%20mechanism,The%20results%20showed%20that')
87. AnnotationURLCitation(end_index=33650, start_index=33556, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=,in%20HCC')
88. AnnotationURLCitation(end_index=34235, start_index=34049, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=reveals%20that%20individual%20KCTD%20proteins,distribution%20patterns%20underlie%20functional%20differences')
89. AnnotationURLCitation(end_index=34711, start_index=34525, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=reveals%20that%20individual%20KCTD%20proteins,distribution%20patterns%20underlie%20functional%20differences')
90. AnnotationURLCitation(end_index=34990, start_index=34813, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=particular%2C%20KCTD15%20inhibits%20neural%20crest,involved%20in%20the%20ubiquitination%20and')
91. AnnotationURLCitation(end_index=36047, start_index=35890, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=KCTD8%20and%20KCTD12%20Facilitate%20Axonal,Transl%20Psychiatry%205%3Ae510')
92. AnnotationURLCitation(end_index=36188, start_index=36048, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=KCTD%20Hetero,that%20assemble%20into%20molecularly%20and')
93. AnnotationURLCitation(end_index=36431, start_index=36260, title='Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/25689571/#:~:text=Altered%20emotionality%20and%20neuronal%20excitability,well%20as%20auxiliary%20KCTD8%2C%2012')
94. AnnotationURLCitation(end_index=36583, start_index=36432, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=The%20BTB%20%28Bric,physiological%20processes%20such%20as%20protein')
95. AnnotationURLCitation(end_index=37944, start_index=37843, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=,Google%20Scholar')
96. AnnotationURLCitation(end_index=38102, start_index=37945, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=duration%20of%20slow%20IPSCs,current%20responses%20in%20the%20hippocampus')
97. AnnotationURLCitation(end_index=38467, start_index=38310, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=duration%20of%20slow%20IPSCs,current%20responses%20in%20the%20hippocampus')
98. AnnotationURLCitation(end_index=39423, start_index=39322, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=,Google%20Scholar')
99. AnnotationURLCitation(end_index=39668, start_index=39563, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=,PMC%20free%20article')
100. AnnotationURLCitation(end_index=39990, start_index=39842, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=auxiliary%20subunits%20constitute%20receptor%20subtypes,12b%20mediate')
101. AnnotationURLCitation(end_index=40125, start_index=39991, title='Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23035119/#:~:text=which%20binds%20to%20GABA,to%20the%20H1%20domains%20but')
102. AnnotationURLCitation(end_index=40469, start_index=40305, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=reveal%20that%20KCTD12%2FKCTD16%20hetero,one%20min%29%20KCTD12%2FKCTD16%20hetero')
103. AnnotationURLCitation(end_index=40627, start_index=40470, title='KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6596860/#:~:text=duration%20of%20slow%20IPSCs,current%20responses%20in%20the%20hippocampus')
104. AnnotationURLCitation(end_index=40974, start_index=40813, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=remains%20unclear%20whether%20and%20how,a%20significant%20decrease%20in%20the')
105. AnnotationURLCitation(end_index=41093, start_index=40975, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=GABA_,related%20memory%20processes')
106. AnnotationURLCitation(end_index=41495, start_index=41321, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=Results%3A%20KCTD8%20was%20methylated%20in,vivo%20via%20inhibiting%20PI3K%2FAKT%20pathway')
107. AnnotationURLCitation(end_index=41590, start_index=41496, title='Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11370965/#:~:text=,in%20HCC')
108. AnnotationURLCitation(end_index=41944, start_index=41800, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=KCTD8%20and%20KCTD16%20also%20interacted,also%20yielded%20a%20BRET%20signal')
109. AnnotationURLCitation(end_index=42084, start_index=41945, title='KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family', type='url_citation', url='https://www.mdpi.com/1422-0067/24/18/14317#:~:text=involved%20in%20shaping%20GABA_,Nluc%2C%20and%20the%20strongest%20with')
110. AnnotationURLCitation(end_index=42401, start_index=42240, title='Organization and functions of mGlu and GABAB receptor complexes | Nature', type='url_citation', url='https://www.nature.com/articles/nature20566#:~:text=that%20the%20molecular%20complexity%20of,mental%20health%20and%20neurological%20disorders')
111. AnnotationURLCitation(end_index=42737, start_index=42601, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=Taking%20into%20account%20the%20close,and%20of%20the')
112. AnnotationURLCitation(end_index=42880, start_index=42738, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4431850/#:~:text=and%20F%20,the%20extensive%20literature%20functional%20and')
113. AnnotationURLCitation(end_index=43240, start_index=43096, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=the%20KCTDs%20in%20the%20mouse,KCTD8%20and%2012b%20a%20restricted')
114. AnnotationURLCitation(end_index=43391, start_index=43241, title='Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21452234/#:~:text=brain%2C%20KCTD12%20and%2016%20have,suggesting%20that%20the%20role%20of')